Home » Newsletters » BioWorld Science

BioWorld Science

March 7, 2002

View Archived Issues

Research reveals mechanism of prostacyclin synthase gene transfer in injured vessels

Further benefit of atorvastatin found in dyslipidemic patients

HCT-1026 diminishes restenosis in an animal model of angioplasty

G-3139 and doxorubicin exhibit favorable interaction in breast cancer model

Cordase as a safe and effective alternative to surgery in Dupuytren's disease

Monotherapy with angiostatic steroid safe in patients with subfoveal AMD

Carotenoids appear to function as ocular antioxidants and to protect against AMD and cataracts

Nymox selects clinical Alzheimer's disease candidate

Posurdex provides higher and more sustained intravitreous drug levels than free dexamethasone

Genentech defines MTD for antiangiogenic antibody fragment in AMD

Antiacne prodrug designed at Tamarkin as potentially safer and more effective than current therapies

Uncoupling protein 3 polypeptides for the treatment of obesity and diabetes

Beta3-adrenoceptor agonists with utility in type 2 diabetes

Antagonists of ETA and ETB receptors with potential utility in circulatory disorders

Gamma-amino acid compounds as GABA analogues with use in epilepsy, etc.

Inhibitors of the ileal bile acid transporter claimed for the treatment of atherosclerosis

Novuspharma describes preparation and use of antitumor compounds

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...